Your session is about to expire
← Back to Search
INTEGRATE-D for Diabetes
N/A
Waitlist Available
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Primary care practices are affiliated with the Oregon Rural Practice-Based Network (ORPRN), at time of recruitment.
Primary care practices must be located in Oregon.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline screening at 15 months
Awards & highlights
Study Summary
This study is evaluating whether a package of implementation strategies can help primary care practices integrate medical and psychosocial care for patients with type 2 diabetes.
Eligible Conditions
- Diabetes
- Primary Care
- Mental Health
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 15 months, post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 15 months, post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of intervention
Appropriateness of the intervention
Feasibility of the intervention
Secondary outcome measures
Hemoglobin A1c
Patient Health Questionnaire-9
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
INTEGRATE-D is a step-by-step blueprint that will assist practices with employing American Diabetes Association recommendations for integrating medical and psychosocial care. INTEGRATE-D consists of a set of implementation strategies that enable clinical teams to put evidence-based care in place. The intervention consists of training and education; audit and feedback materials; a facilitation implementation protocol; and health information technology support materials.
Group II: Control ArmActive Control1 Intervention
Usual care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
INTEGRATE-D
2020
N/A
~300
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
973 Previous Clinical Trials
6,845,735 Total Patients Enrolled
3 Trials studying Diabetes
376 Patients Enrolled for Diabetes
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger